Patheon, a leading provider of contract development and manufacturing services to the global pharmaceutical industry, has been awarded a 2010 European Outsourcing Award for the most effective scale-up/technology transfer. The award focuses on capacity issues or transfer from lab to full-scale production.
‘It is a great honor to be recognised among many leaders in our industry. This award demonstrates our experience in managing and completing technology transfers within a very compressed timeframe, with no interruption of supply, no decrease in quality, and exceeding the new regulatory standards,’ said Wes Wheeler, Patheon's ceo and president.
‘Our clients generally choose us over our competition for our state-of-the-art of the facilities, specialising in sterile production, and for our expert knowledge of aseptic filling and terminal sterilisation. Paradoxically, we are receiving this award as we launch a new promotion program to eliminate up-front technology transfer costs for any guaranteed volume lyophilisation commercial agreement.’
This award is given each year by an EU-based committee of industry experts. It honors companies that have shown evidence of an innovative, cost-effective and regulatory compliant partnership that effectively brought a product to market and maintained the strict criteria of safety, efficacy and consistency. Judges selected Patheon among numerous competitors after a rigorous selection process.
Patheon was also finalist for the European Outsourcing Award in the Best Contract Manufacturing Project category.